Skip to main content
Clinical Trials/CTRI/2016/01/006492
CTRI/2016/01/006492
Completed
Phase 4

To assess the performance and clinical effectiveness of a combination of SJM mapping and ablation products in the treatment of subjects with atrial fibrillation. - ABLATOR Ablation Observational Registry

St Jude Medical India Pvt Ltd0 sites2,035 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with Atrial Fibrillation
Sponsor
St Jude Medical India Pvt Ltd
Enrollment
2035
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 18, 2017
Last Updated
4 years ago
Study Type
Pms

Investigators

Sponsor
St Jude Medical India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • All patients from participating sites who are indicated for an atrial fibrillation ablation procedure and willing to provide written Informed Consent may be enrolled in this registry.

Exclusion Criteria

  • Patient not willing to sign informed consent form

Outcomes

Primary Outcomes

Not specified

Similar Trials